MEDVi vs WeightWatchers (Sequence): Which GLP-1 Provider Is Better?

By Iacob Pastina, Independent Researcher

48 providers verified independently·Independent research·How we rank →

MEDVi beats WeightWatchers (Sequence) overall, scoring 7.7/10 vs 7.4/10. MEDVi is more affordable at $299/mo vs $423/mo. Choose MEDVi for users who want a low entry price with oral and injectable co. Choose WeightWatchers (Sequence) for users who want glp-1 medication combined with the weightwatc.

A side-by-side comparison of MEDVi and WeightWatchers (Sequence) covering pricing, scores, medication types, insurance, and more to help you decide.

Higher Rated

MEDVi

#22 of 48

7.7/10

MEDVi is a compounded GLP-1 telehealth platform offering both oral tablets and injectable semaglutide and tirzepatide, with micro-dosing options for side-effect-sensitive patients. $179/mo entry pricing, free shipping, and a streamlined intake — one of the broader compounded mixes among independent telehealth providers in 2026.

Visit MEDVi

WeightWatchers (Sequence)

#29 of 48

7.4/10

WeightWatchers' clinical weight management arm (acquired from Sequence). Membership is tiered: 12-month plan first month $149-$299 depending on tier, then $74/mo ongoing for months 2-12; shorter plans are higher per-month. Medication billed separately: $199/mo intro for 2 months, then $349/mo ongoing. Lineup includes Saxenda (liraglutide brand), Wegovy, Zepbound, and compounded semaglutide/tirzepatide.

Visit WeightWatchers (Sequence)

Feature	MEDVi	WeightWatchers (Sequence)
Our Score	7.7/10	7.4/10
Starting Price	$299/mo	$423/mo
Medication Type	Both	Both
Insurance Accepted	No	Yes
Best For	Users who want a low entry price with oral and injectable compounded options	Users who want GLP-1 medication combined with the WeightWatchers program and community — $74 ongoing membership (on 12-month plan, $149-$299 first month) + $349 ongoing medication = $423/mo all-in
Ranking	#22	#29

Pros & Cons Compared

MEDVi

Pros

+One of the few compounded providers offering both oral tablets and injectable semaglutide
+Micro-dosing options available — can start at sub-standard doses for patients concerned about side effects
+Sleek onboarding experience with clear progress tracking through their patient portal
+$179/mo is competitive for a platform with both oral and injectable compounded formulations

Cons

−Compounded medications only — no path to brand-name Wegovy or Zepbound through their platform
−No insurance accepted, and oral compounded semaglutide has less clinical data than injectable forms

WeightWatchers (Sequence)

Pros

+Combines GLP-1 medication with WeightWatchers' proven points system and community support
+Insurance accepted for medication — can reduce costs significantly with qualifying plans
+Decades of brand trust and weight loss expertise applied to clinical medication management
+Access to WW community, workshops, and digital tools alongside medication

Cons

−$269/mo without insurance is expensive for what's included clinically
−The WW program integration adds complexity that medication-only users won't value
−The Sequence acquisition is still integrating — some operational inconsistencies remain
−Less medication flexibility than pure-play GLP-1 platforms

Our Verdict

MEDVi edges out WeightWatchers (Sequence) with a score of 7.7/10 vs 7.4/10. If budget is your priority, MEDVi starts at $299/mo compared to WeightWatchers (Sequence)'s $423/mo. WeightWatchers (Sequence) accepts insurance, which can significantly reduce your out-of-pocket costs. Choose MEDVi if you want: users who want a low entry price with oral and injectable compounded options. Choose WeightWatchers (Sequence) if you want: users who want glp-1 medication combined with the weightwatchers program and community — $74 ongoing membership (on 12-month plan, $149-$299 first month) + $349 ongoing medication = $423/mo all-in.

Still undecided? Editor's #1 Overall Pick

Embody

$299/mo · 7.3/10 · Compounded

If neither MEDVi nor WeightWatchers (Sequence) feels like the right fit, our overall #1 pick across all 48 GLP-1 telehealth providers is Embody — strongest balance of clinical oversight, transparent pricing, and verified availability.

Visit Embody→Read our full Embody review